Influence of SPK with Enteric Drainage on the Pancreatic Exocrine Function in Diabetic Patients with Uremia
Table 2
Comparison of blood glucose and pancreatic islet function among study groups.
Variable
SPK ()
RT ()
CRF ()
CON ()
Blood glucose (mmol/L), median (IQR)
5.0 (5.6-5.2)
6.1 (5.4–7.3)##
7.7 (6.9, 8.8)##
4.0 (3.8-4.3)##
<0.001
Glycosylated hemoglobin (%), median (IQR)
4.8 (4.2-5.2)
7.3 (6.7–8.3)##
7.5 (6.7–8.8)##
4.2 (4.0-5.0)
<0.001
Insulin (μIU/mL), median (IQR)
6.8 (5.8–8.3)
4.8 (4.0-5.3)##
5.3 (3.6–6.4)##
7.7 (6.0–8.8)
<0.001
C-peptide (ng/mL), median (IQR)
4.2 (3.6–6.5)
3.4 (2.9-3.5)##
3.4 (2.5–4.0)##
4.7 (4.3-5.7)
<0.001
FPE (μg/g), median (IQR)
479 (335–557)
197 (185–502)#
229 (163–457)##
441 (341–554)
0.003
<200 μg/g (%)
1 (5.3)
12 (54.5)
14 (45.2)
1 (5.0)
<0.001
≧200 μg/g (%)
18 (94.7)
20 (45.5)
17 (54.8)
19 (95.0)
Comparison among four groups; #compared with the SPK group, ; ##compared with the SPK group, . SPK: simultaneous pancreas–kidney transplantation; CRF: diabetic patients with uremia (chronic renal failure); RT: diabetic patients with uremia who underwent renal transplantation; CON: normal individuals; FPE: fecal pancreatic elastase.